Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)

Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)

US Patent 8487131 · Granted Jul 16, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of cancer invasion, attachment, and/or metastasis2024
EPHA2 agonists and uses thereof2023
Therapeutic compounds and methods2023
Agents targeting inhibitor of apoptosis proteins2023
Inhibitors of cancer invasion, attachment, and/or metastasis2021
Inhibitors of Furin and other pro-protein convertases2016
Naphthalene-based inhibitors of anti-apoptotic proteins2015
Apogossypolone derivatives as anticancer agents2015
Naphthalene-based inhibitors of anti-apoptotic proteins2013
Bi-dentate compounds as kinase inhibitors2013
Methods and compounds useful to induce apoptosis in cancer cells2013
Naphthalene-based inhibitors of anti-apoptotic proteins2011